Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$480K Sell
7,129
-113
-2% -$7.53K 0.01% 330
2026
Q1
$455K Buy
7,242
+1,889
+35% +$132K 0.01% 326
2025
Q4
$355K Buy
+5,353
New +$346K 0.01% 354
2024
Q2
Sell
-6,339
Closed -$884K 439
2024
Q1
$884K Buy
+6,339
New +$797K 0.01% 293

Other funds holding DXCM

Perpetual Ltd's DXCM Position: Q2 2026 in Review

Perpetual Ltd reduced its DexCom (DXCM) stake by 1.6% in Q2 2026, selling an estimated $7.53K and leaving 7,129 shares worth $480K. The position accounts for 0.01% of the portfolio, ranked #330.

Perpetual Ltd first reported a position in DXCM in Q1 2024 and has held it in 4 quarters since. The position peaked at $884K in Q1 2024. 306 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Perpetual Ltd held 7,129 shares of DexCom worth $480K as of Q2 2026.
  • Perpetual Ltd sold 113 DexCom shares in Q2 2026, an estimated $7.53K.
  • DexCom made up 0.01% of Perpetual Ltd's portfolio in Q2 2026, its #330 holding.
  • Perpetual Ltd first reported a position in DexCom in Q1 2024 and has held it in 4 quarters since.
  • Perpetual Ltd's DexCom position peaked at $884K in Q1 2024.
  • 306 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Perpetual Ltd's 13F filing for Q2 2026, filed 15 Jul 2026.